Information  X 
Enter a valid email address

Beximco Pharmaceuticals sees 'material difference' in year-end results as profit rises in H1

By BFN News | 09:46 AM | Thursday 28 January, 2021

Manufacturer of generic pharmaceutical Beximco Pharmaceuticals said it expected to see 'material difference' in its annual results after report a rise in half-year profit on increased sales For the six months ended 31 December 2020, pre-tax profit rose to £3.0 million taka (BDT) from 2,980 million as revenue grew to £14,400 million from £12,495 million. Net sales increased 20.7% to BDT 7,474.3 million. 'Looking ahead, we maintain a positive outlook for FY21 and reiterate, in line with the announcement on 14 January 2021, that while the costings of our vaccine distribution have yet to be determined, we expect to see a positive material difference to the company's year-end results,' the company said. At 9:46am: (LON:BXP) Beximco Pharmaceuticals Ltd share price was 0p at 81.5p Story provided by

a d v e r t i s e m e n t